onc Videos

Videos

Conference Coverage

Routine Screening for Brain Metastases Among Patients With HER2-Positive Breast Cancer

05/14/2024

Laura Huppert, MD

At Great Debates and Updates in Women’s Oncology, Laura Huppert, MD, argued that routine screening for brain metastases is unnecessary for patients with either early or metastatic HER2-positive breast cancer.

At Great Debates and Updates in...

05/14/2024

Oncology

Conference Coverage

Should Pemetrexed Be Continued in Patients Who Receive the KEYNOTE-189 Regimen?

05/14/2024

Featuring Edward Garon, MD, MS

Featuring Edward Garon, MD, MS ...

At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Edward Garon, MD, MS, argued that pemetrexed maintenance therapy should eventually be stopped.

At the Great Debates and Updates...

05/14/2024

Oncology

Conference Coverage

Advantages to Continuing Pemetrexed as Maintenance Therapy in the KEYNOTE-189 Regimen

05/14/2024

Corey Langer, MD

At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Corey Langer, MD, argued that continuing pemetrexed maintenance therapy is advantageous for patients treated with the KEYNOTE-189 regimen.

At the Great Debates and Updates...

05/14/2024

Oncology

Videos

Management Considerations for Oral Toxicities Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma

05/10/2024

Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.

Samantha Shenoy, NP, discusses...

05/10/2024

Oncology

Seth Wander, MD, PhD, Massachusetts General Hospital

Videos

Novel Endocrine Agents for Patients With HR-Positive Breast Cancer

05/08/2024

Featuring Seth Wander, MD, PhD

Featuring Seth Wander, MD, PhD ...

At Great Debates and Updates in Women’s Oncology, Seth Wander, MD, PhD, discussed whether novel endocrine agents add anything different from SERDs to treatments for patients with hormone receptor-positive metastatic breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Videos

The Case for Platinum-Based Chemotherapy for Patients With Platinum-Sensitive Recurrent Ovarian Cancer

05/08/2024

Featuring Ying Liu, MD, MPH

At the 2024 Great Debates and Updates in Women’s Oncology meeting, Ying Liu, MD, MPH, makes an argument for platinum-based chemotherapy as the optimal treatment for patients with platinum-sensitive recurrent ovarian cancer.

At the 2024 Great Debates and...

05/08/2024

Oncology

Denise Yardley, MD, Sarah Cannon Research Institute

Videos

Is Age 50 Relevant for Decisions in Early HR-Positive Breast Cancer?

05/08/2024

Featuring Denise Yardley, MD

At Great Debates and Updates in Women’s Oncology, Denise Yardley, MD, discusses whether age 50 is relevant for treatment decisions for patients with early HR-positive breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Neil Iyengar, MD, Memorial Sloan Kettering Cancer Center

Videos

Sequential Antibody Drug Conjugates for Patients With Metastatic Breast Cancer

05/08/2024

Featuring Neil Iyengar, MD

At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.

At Great Debates and Updates in...

05/08/2024

Oncology

Conference Coverage

Use of Liquid Biopsies to Reduce Time to Treatment for Patients With Lung Cancer

05/07/2024

Featuring Christian Rolfo, MD, PhD

Featuring Christian Rolfo, MD, PhD ...

At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that upfront liquid biopsies are an essential part of the initial patient workup.

At the Great Debates and Updates...

05/07/2024

Oncology

Conference Coverage

Discussing the Need of Adjuvant Treatment After Neoadjuvant in Early Stage Lung Cancer

05/06/2024

Featuring Christian Rolfo, MD, PhD

Featuring Christian Rolfo, MD, PhD ...

At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Christian Rolfo, MD, PhD, argued that perioperative immunotherapy should not be used to treat patients with lung cancer.

At the Great Debates and Updates...

05/06/2024

Oncology

Recent News

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology

News

Ipilimumab After PD-1 Inhibition Failure Among Patients With Metastatic Melanoma

11/05/2024

Allison Casey ;

A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.

A single-center real-world study...

11/05/2024

Oncology